• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Ophthalmology

Age-related macular degeneration may be associated with depression risk

byMolly Munsell
February 6, 2023
in 2 Minute Medicine, Chronic Disease, Ophthalmology, Psychiatry
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. In a large population-based cohort, age-related macular degeneration (AMD) diagnosis was associated with increased risk for depression onset.

2. Visual disability related to AMD was associated with a further significant increase in depression risk.

Evidence Rating Level: 2 (Good)

Study Rundown: Age-related macular degeneration (AMD) is one of the most common causes of visual disability and blindness in high-income countries. Thus, managing and living with AMD involves consideration not only of ophthalmic complications like neovascularization but also quality of life and mental health concerns. This prospective study aimed to use a Korean population cohort to quantify the relationship between AMD and depression risk. Among a cohort of about 4 million patients, AMD diagnosis was associated with a 15% increase in risk for incident depression compared to participants without AMD. The presence of significant visual disability associated with AMD was associated with more increased risk — 23% compared to the control group without AMD. This very large cohort study provides compelling evidence for a link between AMD and major depression; this is consistent with past, smaller studies suggesting higher rates of depression in AMD patients than in the overall elderly population. This association is intuitive given the toll sensory impairment often takes on quality of life. Further study is needed on whether and how assistive technology and support services can mitigate this mental health impact, particularly in high-resource settings such as the United States and South Korea.

Click to read the study in Ophthalmology

Relevant Reading: Age-related macular degeneration

RELATED REPORTS

Federal Drug Administration approves Alzheimer’s blood test for use in primary care

Self-Help App for Depression in People With Intellectual Disabilities: A Randomized Clinical Trial

Multidomain rehabilitation after myocardial infarction improves outcomes in older adults

In-Depth [prospective cohort]: Baseline data on AMD status and demographics for patients aged 50 and older were drawn from the Korean National Health Screening Program in 2009. Patients with depression at baseline were excluded. Incidence of major depressive disorder was determined based on new cases through 2019. Visual disability was classified as mild or severe based on ophthalmologist grading through the Korean national disability registry. Cox proportional hazard models adjusted for factors including age, sex, low income status, smoking status, activity level, comorbidities including hypertension, diabetes, and dyslipidemia were used to calculate hazard ratios. The hazard ratio for depression associated with AMD was 1.15 [95% confidence interval (CI) 1.13-1.17]. The presence of visual disability increased the hazard ratio to 1.23 (95% CI 1.16-1.30), with hazard ratios of 1.21 and 1.25 for mild and severe disability, respectively.

Image: PD

©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: age-related macular degenerationAMDchronic diseasedepressiondisabilitymajor depressive disorder (MDD)mental healthvisual impairment
Previous Post

Exercise may be as effective as pharmacotherapy in managing osteoarthritis pain

Next Post

Food hardship relief is associated with fewer pediatric emergency department visits

RelatedReports

FDA-regulated clinical trials rarely report violations
The Scan by 2 Minute Medicine®

Federal Drug Administration approves Alzheimer’s blood test for use in primary care

October 22, 2025
Shared decision-making tool for antidepressants improves patient and physician satisfaction
Chronic Disease

Self-Help App for Depression in People With Intellectual Disabilities: A Randomized Clinical Trial

October 16, 2025
β-blockers linked to improved survival in preserved ejection fraction heart failure
Cardiology

Multidomain rehabilitation after myocardial infarction improves outcomes in older adults

October 15, 2025
Antidepressant may reduce mental stress-induced myocardial ischemia (REMIT Trial)
Cardiology

Aficamten is superior to metoprolol in the management of obstructive hypertrophic cardiomyopathy

October 14, 2025
Next Post
Improved glycemic control in type 1 diabetics on very low-carbohydrate diets

Food hardship relief is associated with fewer pediatric emergency department visits

Colleges can support students with chronic medical conditions

College campus mpox outbreaks can be controlled with timely detection and isolation

PCI not superior to medical therapy alone in stable coronary disease: The COURAGE study

Protein-truncating variants in apolipoprotein B and PCSK9 genes associated with lower exposure to atherogenic LDL cholesterol and risk of coronary heart disease

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • World Health Organization warns that one in six infections now antibiotic resistant
  • Ifinatamab Deruxtecan in Patients With Extensive-Stage Small-Cell Lung Cancer: Primary Analysis of the Phase 2 IDeate-Lung01 Trial
  • Artificial intelligence (AI) may reduce cognitive load for sonographers in fetal ultrasound scans without affecting diagnostic performance
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.